NDC 50102-130-01 - CHATEAL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-130
- Requested NDC
- 50102-130-01
- Package NDCs from labels
- 50102-130-00, 50102-130-01, 50102-130-48, 50102-130-10, 50102-130-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CHATEAL - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-130-03 | 2023-02-24 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-48 | 2023-02-24 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-03 | 2023-01-30 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-48 | 2023-01-30 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-130-00 | EA - Each | 50102-130 | dcb62401-8949-464e-ab16-85f9c6f4c40d | 1 | 2022-06-06 |
| 50102-130-01 | EA - Each | 50102-130 | b8bb767c-e280-45f7-828d-4a8aaae9c21c | 1 | 2013-02-13 |
| 50102-130-03 | EA - Each | 50102-130 | 61c25f8e-2546-4292-98d9-3172853ce2f1 | 1 | 2017-09-11 |
| 50102-130-10 | EA - Each | 50102-130 | 4a3fd139-d25f-40ed-939c-42f8b7d58d0e | 1 | 2017-09-11 |
| 50102-130-48 | EA - Each | 50102-130 | 1a4669e5-b979-4386-ba8b-04d4f4b7e28e | 1 | 2013-02-13 |
| 50102-130-90 | EA - Each | 50102-130 | 3536e405-15d6-482b-949b-31b922af726b | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hailey 1.5/30 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 021df70a-0c37-4237-a2f7-2597ff6d41f5 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Norethindrone Acetate and Ethinyl Estradiol | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | cf549b5a-2707-4020-9f94-dab1260e1664 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| ZAFEMY | NORELGESTROMIN AND ETHINYL ESTRADIOL | AvKARE | fbbd12dd-c538-2869-e053-6294a90a1a38 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Fyavolv | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | 772c86d7-10a4-48c5-8c19-f8aac68f5ab4 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Her Style | LEVONORGESTREL | Ingenus Pharmaceuticals, LLC | 6e631755-b7c5-4a3a-b46d-f66b4ceedb1c | 2025-12-05 | Warnings | 5W7SIA7YZW |
| New Day | LEVONORGESTREL | Northstar Rx LLC | 9e8c96f6-ab51-4721-b276-1ca02a712510 | 2025-12-05 | Warnings | 5W7SIA7YZW |
| My Way | LEVONORGESTREL | Lupin Pharmaceuticals, Inc. | 3efec61d-e0a6-49c5-9b88-834db6d171fd | 2025-12-02 | Warnings | 5W7SIA7YZW |
| Julie Morning After Pill | LEVONORGESTREL | Julie Products Inc. | 40bb96f0-d5f1-1ec3-e063-6294a90a74b1 | 2025-11-26 | Warnings | 5W7SIA7YZW |
| Julie Morning After Pill | LEVONORGESTREL | Julie Products Inc. | 40bbad6f-0c54-e4ed-e063-6394a90af3ad | 2025-11-14 | Warnings | 5W7SIA7YZW |
| NuvaRing | ETONOGESTREL AND ETHINYL ESTRADIOL | Organon LLC | 55eb60e3-6f4d-40a3-8ee6-e7fd2d0c7d97 | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Mirena | LEVONORGESTREL | Bayer HealthCare Pharmaceuticals Inc. | dcbd6aa2-b3fa-479a-a676-56ea742962fc | 2025-10-29 | Warnings, Adverse reactions | 5W7SIA7YZW |
| Kyleena | LEVONORGESTREL | Bayer HealthCare Pharmaceuticals Inc. | 2e07c155-21e1-4781-9633-ce8bddd47080 | 2025-10-23 | Warnings, Adverse reactions | 5W7SIA7YZW |
| NUVARING | ETONOGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | 524c7188-ee84-4d5c-a6ab-e7a5ae36e22b | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Julie | LEVONORGESTREL | Julie Products Inc | 2e9784da-2186-a630-e063-6294a90a8493 | 2025-07-14 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | Ohm Laboratories Inc. | f3f2a41a-a9af-4d63-81d8-33181d12af40 | 2025-07-04 | Warnings | 5W7SIA7YZW |
| AfterPill | LEVONORGESTREL | Syzygy Healthcare Solutions, LLC PO Box 588, Westport, CT 06880 | 4d284ba4-9cd7-48e4-95b9-cd6d0367bfd1 | 2025-05-01 | Warnings | 5W7SIA7YZW |
| PostDay One-Step | LEVONORGESTREL | Home Health Brands, LLC | 01c8c95c-6fbe-4068-915d-74418a6bb570 | 2025-04-23 | Warnings | 5W7SIA7YZW |
| LUIZZA 1/20 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Xiromed, LLC | 88d90f33-1034-4d27-034f-11d9c441c9e7 | 2025-04-21 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Morning After Pill | LEVONORGESTREL | Cadence Health Inc | 2fb59f53-d885-9d4a-e063-6394a90a88cc | 2025-04-15 | Warnings | 5W7SIA7YZW |
| EContra One-Step | LEVONORGESTREL | Afaxys Pharma, LLC | 94b23c49-dfba-4a70-ada5-e5c212e703c5 | 2025-04-08 | Warnings | 5W7SIA7YZW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.